Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT05172284

Registry and Monitoring of ImmuNe-mediated Inflammatory Diseases

Formation of a registry of IMID patients to assess the evolution of resistance to conventional and target therapies. This aim is achieved by evaluating the achievement of PASI 50 and PASI 75 scores at week 16 from the start of treatment.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

ImmuNe-Mediated Inflammatory Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

IRCCS Istituto Ortopedico Galeazzi

Milan, 20161, Italy

Location contact

Giovanni Damiani, Dr.

CONTACT

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with a diagnosis of IMID.
  • Patients of any age, including minors.
  • Patients treated with approved medications for the condition in question and/or phototherapy.
  • Patients who agree to sign informed consent.

Exclusion criteria

  • Patients without a diagnosis of IMID.
  • Patients who do not consent to sign informed consent.

Treatment and study plan

questionnaires

Other

This is a collection of data from normal clinical routine: patients will be asked to record the assessments they undergo during their course of treatment, without changing clinical practice in any way. Data inherent to the following procedures will be collected: examinations, laboratory tests, imaging tests, questionnaires and rating scales.

Other names: blood tests, instrumental and/or imaging examinations, rating scales

Primary outcomes

  1. Registry of ImmuNe-mediated inflammatory Diseases (IMIDs)

    Time frame: 15 years

    Formation of a registry of IMID patients to assess the evolution of resistance to conventional and target therapies.

Secondary outcomes

  1. PASI 50

    Time frame: 15 years

    Assess attainment of PASI 50 score from the start of treatment to all follow-ups

  2. PASI 75

    Time frame: 15 years

    Assess attainment of PASI 75 score from the start of treatment to all follow-ups

Other outcomes

  1. Special populations

    Time frame: 15 years

    Quantification and monitoring of IMID patients belonging to "special populations". Special populations include: homeless, transgender, amputees, para and quadriplegics.

Study contacts

Contact information is provided by the study sponsor or research team.

Giovanni Damiani, Dr.

CONTACT

[email protected]

393929403679

Sponsors and collaborators

Lead sponsor

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Other

Registry information

Official study title

Registry and Monitoring of ImmuNe-mediated Inflammatory Diseases (IMIDs) REMIND Study

Important dates

Study start
2022
Primary completion
2023
Study completion
2026
First posted
Dec 29, 2021
Registry last updated
Jan 11, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.